NeurOp
NeurOp, Inc. is a preclinical-stage biopharmaceutical company developing disease-activated medicines for the treatment of central nervous system disorders, including major depression, neuropathic pain, and ischemia. We are partnered with Bristol-Myers Squibb Company in a funded license/research collaboration to develop some of our opportunities.
For more information, visit NeurOp, Inc. at their company website.
